Jefferies Financial Group’s Avita Medical RCEL Stock Holding History

Jefferies Financial Group’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$440K	Buy	+37,500	New	+$297K	﹤0.01%	999

Other funds holding RCEL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Thompson Davis & Co Richmond, Virginia $149M AUM 10.53% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Jefferies Financial Group's RCEL Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Avita Medical (RCEL) in Q3 2026: 37,500 shares worth $440K. The stake represents ﹤0.01% of the portfolio and ranks #999 among its holdings.

21 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

Jefferies Financial Group held 37,500 shares of Avita Medical worth $440K as of Q3 2026.
Avita Medical was a new Jefferies Financial Group position in Q3 2026.
Avita Medical made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #999 holding.
21 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.